HIGHLIGHTS
- who: Sang-Ho Jeong et al. from the Department of Surgery, Gyeongsang National University Changwon Hospital have published the paper: Efficacy of S-1 or Capecitabine Plus Oxaliplatin Adjuvant Chemotherapy for Stage II or III Gastric Cancer after Curative Gastrectomy: A Systematic Review and Meta-Analysis, in the Journal: Cancers 2022, 3940 of /2022/
- what: The aim of this meta-analysis was to compare the overall survival (OS) and disease-free survival (DFS) of the S-1 and CAPOX regimens as AC, focusing on oncologic outcomes at five years after curative gastrectomy for AGC.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.